Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2008 1
2009 1
2012 1
2013 2
2014 4
2015 6
2016 4
2017 2
2018 5
2019 2
2020 5
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.
Magnes T, Melchardt T, Weiss L, Hufnagl C, Greil R, Egle A. Magnes T, et al. Among authors: hufnagl c. J Clin Oncol. 2016 Jul 10;34(20):2433-4. doi: 10.1200/JCO.2016.66.6057. Epub 2016 May 9. J Clin Oncol. 2016. PMID: 27161962 No abstract available.
Evaluation of a novel flow diverter, the DiVeRt system, in an animal model.
Hufnagl C, Broussalis E, Cognard C, Grimm J, Hecker C, Oellerer A, Abdallah M, Griessenauer CJ, Killer-Oberpfalzer M. Hufnagl C, et al. J Neurointerv Surg. 2022 Apr;14(4):384-389. doi: 10.1136/neurintsurg-2021-017430. Epub 2021 May 13. J Neurointerv Surg. 2022. PMID: 33986108
DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer.
Gampenrieder SP, Rinnerthaler G, Hackl H, Pulverer W, Weinhaeusel A, Ilic S, Hufnagl C, Hauser-Kronberger C, Egle A, Risch A, Greil R. Gampenrieder SP, et al. Among authors: hufnagl c. Theranostics. 2018 Mar 11;8(8):2278-2288. doi: 10.7150/thno.23544. eCollection 2018. Theranostics. 2018. PMID: 29721079 Free PMC article.
Circulating tumor DNA to monitor metastatic breast cancer.
Weiss L, Hufnagl C, Greil R. Weiss L, et al. Among authors: hufnagl c. N Engl J Med. 2013 Jul 4;369(1):93. doi: 10.1056/NEJMc1306040. N Engl J Med. 2013. PMID: 23822790 Free article. No abstract available.
Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients.
Schlick K, Hohla F, Hamacher F, Hackl H, Hufnagl C, Markus S, Magnes T, Gampenrieder SP, Melchardt T, Stättner S, Hauser-Kronberger C, Greil R, Rinnerthaler G. Schlick K, et al. Among authors: hufnagl c. Future Sci OA. 2020 Nov 30;7(2):FSO644. doi: 10.2144/fsoa-2020-0128. Future Sci OA. 2020. PMID: 33437513 Free PMC article.
The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes T, Melchardt T, Hufnagl C, Weiss L, Mittermair C, Neureiter D, Klieser E, Rinnerthaler G, Roesch S, Gaggl A, Greil R, Egle A. Magnes T, et al. Among authors: hufnagl c. Pharmacogenomics J. 2018 May 22;18(3):474-479. doi: 10.1038/tpj.2017.37. Epub 2017 Jul 18. Pharmacogenomics J. 2018. PMID: 28719596
31 results